Clinical Research Directory
Browse clinical research sites, groups, and studies.
National Longitudinal Cohort of Hematological Diseases (NICHE) - CART
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Summary
This is a multicenter, ambispective, longitudinal, observational cohort study investigating CAR-T cell therapy in Chinese patients with hematological malignancies. A consortium of Phase IV clinical trials and real-world studies of Chimeric antigen receptors (CAR) T cell therapy will be established in China. Patient-level data from these studies will be collected to create a large real-world cohort. In addition, patients receiving CAR-T cell therapy for hematological malignancies identified from an existing hematology longitudinal cohort study, the National Longitudinal Cohort of Hematological Diseases (NICHE), will also be included in the study.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2021-06-01
Completion Date
2032-12-31
Last Updated
2025-06-17
Healthy Volunteers
No
Conditions
Locations (1)
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China